Management Team

Glenn Batchelder

Executive Chair

Mr. Glenn Batchelder previously was Co-Founder and CEO of Civitas Therapeutics, a development stage pulmonary delivery therapeutic company based on the ARCUS technology platform that was sold to Acorda Therapeutics.

Prior to Civitas he served as CEO of BIND Biosciences (acquired by Pfizer), CEO of Acceleron Pharma (NASDAQ: XLRN) and SVP of Operations at Millennium Pharmaceuticals (acquired by Takeda).

During his more than 30 years of executive leadership experience he also served in functional roles including sales, marketing, business development, manufacturing, supply chain management and R&D.

He currently serves as Chairman of the Board for Synchronicity Pharma and XyloCor Therapeutics and serves on the board of directors for Synspira. He also serves on the non-profit board of directors for the Michael J. Fox Foundation for Parkinson’s Research and The Possible Project. He is the former Chairman of the MassBio board.

‍

Sylvie Breton

Professor Sylvie Breton, PhD, is a Professor of Medicine at Harvard Medical School, and directs the Breton Laboratory within the Program in Membrane Biology / Center for Systems Biology in the Nephrology Division at the Massachusetts General Hospital.

View bio

John Randle

Dr. John C.R. Randle, PhD, brings over 30 years of practical, hands-on experience to the business of drug candidate selection and development.

View bio

Andrea Franz

Ms. Franz is a financial executive with over 25 years of experience in small to mid-size biotechnology companies.

View bio

Dennis Ausiello, MD

Dennis A. Ausiello, MD, is the Director of the Center for Assessment Technology and Continuous Health (CATCH) at MGH; Jackson Distinguished Professor of Clinical Medicine, Emeritus at Harvard Medical School; and the Physician-in-Chief, Emeritus of the Department of Medicine at MGH.

View bio

Dennis Brown, PhD

Prof. Dennis Brown is an internationally recognized expert on renal physiology and kidney function at the Massachusetts General Hospital (Nephrology Division) and Harvard Medical School.

View bio

Martin Freed, MD

Dr. Martin Freed brings more than 25 years of strategic development and operational expertise from across the biopharmaceutical and life sciences industries.

View bio

Todd Rosengart, MD

Dr. Todd Rosengart is a nationally recognized cardiothoracic surgeon, a National Institutes of Health (NIH)-supported scientist, and an extensively published investigator.

View bio

Sushrat Waikar, MD, Mph

Sushrut Waikar, MD, MPH, Clinical Advisor, is Associate Professor of Medicine, BWH/HMS. He is Director of Translational Research and Ambulatory Services, BWH and is an expert in acute and chronic kidney disease.

View bio

Winfred W. Williams, MD

Winfred W. Williams, MD, Medical Advisor, is Nephrologist and Associate Chief of the Division of Nephrology at MGH/HMS. He is Director of the Program in Interventional Nephrology for the Transplantation Unit at MGH.

View bio

Glenn Batchelder

Sylvie Breton

John Randle

Andrea Franz

Dennis Ausiello, MD

Dennis Brown, PhD

Martin Freed, MD

Todd Rosengart, MD

Sushrat Waikar, MD, Mph

Winfred W. Williams, MD

Kantum Pharma